PepsiCo Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1087
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:170
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PepsiCo Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by PepsiCo Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes PepsiCo Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by PepsiCo Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on PepsiCo Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by PepsiCo Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for PepsiCo Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about PepsiCo Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 7
LIST OF FIGURES 7
TARGETS AND PARTNERS 8
MERGERS & ACQUISITIONS 9
Mergers and Acquisitions – Overview 9
Mergers and Acquisitions – Deal reports 10
CORPORATE VENTURING 68
Corporate Venturing – Deal reports 68
PARTNERSHIP 72
Partnership – Overview 72
Partnership – Deal reports 73
CAPITAL RAISING 106
Capital Raising – Overview 106
Capital Raising – Deal reports 107
DIVESTMENTS 129
Divestments – Overview 129
Divestments – Deal reports 130
PRIVATE EQUITY & OWNERSHIP 156
Private Equity and Ownership – Deal reports 156
APPENDIX 160
Contact Us 160
About MarketLine Financial Deals Database 160
Deal Definition and Methodology 162
About MarketLine 169

List of Tables
Table 1: PepsiCo M&A volume and value trend (2014-YTD2018)
Table 2: PepsiCo M&A activity by geography (2014-YTD2018)
Table 3: PepsiCo partnership volume and value trend (2014-YTD2018)
Table 4: PepsiCo partnership trend by key deal type (2014-YTD2018)
Table 5: PepsiCo capital raising volume and value trend (2014-YTD2018)
Table 6: PepsiCo capital raising by deal type (2014-YTD2018)
Table 7: PepsiCo divestments volume and value trend (2014-YTD2018)
Table 8: PepsiCo divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: PepsiCo M&A volume and value trend (2014-YTD2018)
Figure 2: PepsiCo M&A activity by geography (2014-YTD2018)
Figure 3: PepsiCo partnership volume and value trend (2014-YTD2018)
Figure 4: PepsiCo partnership trend by key deal type (2014-YTD2018)
Figure 5: PepsiCo capital raising volume and value trend (2014-YTD2018)
Figure 6: PepsiCo capital raising by deal type (2014-YTD2018)
Figure 7: PepsiCo divestments volume and value trend (2014-YTD2018)
Figure 8: PepsiCo divestments by geography (2014-YTD2018)

★海外企業調査レポート[PepsiCo Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • CohBar Inc (CWBR):製薬・医療:M&Aディール及び事業提携情報
    Summary CohBar Inc (CohBar) is a developer of mitochondria based therapeutics. The company develops a class of drugs to treat a wide range of diseases associated with aging and metabolic dysfunction such as non-alcoholic steatohepatitis, obesity, type 2 diabetes, cancer, cardiovascular disease and C …
  • ESI Group S.A. (ESI):企業の財務・戦略的SWOT分析
    ESI Group S.A. (ESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Zimnat Group:企業の戦略・SWOT・財務情報
    Zimnat Group - Strategy, SWOT and Corporate Finance Report Summary Zimnat Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • SELEX Galileo Inc.:企業の戦略・SWOT・財務情報
    SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report Summary SELEX Galileo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Caldera Health Ltd:製品パイプライン分析
    Summary Caldera Health Ltd (Caldera) is a medical device company that develops prostate cancer diagnostic tools. The company develops prostate cancer diagnostic tools to detect and monitor the cancer disease. It also develops proscanZ and auditor tests based on the enzyme linked immunoassays or ELIS …
  • MedX Health Corp (MDX):企業の財務・戦略的SWOT分析
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Navistar International Corp (NAV):企業の財務・戦略的SWOT分析
    Navistar International Corp (NAV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • RRB Energy Ltd:企業の戦略的SWOT分析
    RRB Energy Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica), formerly DiaMedica Inc is a clinical-stage biopharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 a …
  • University of Texas Southwestern Medical Center-医療機器分野:企業M&A・提携分析
    Summary University of Texas Southwestern Medical Center (UTSMC), a subsidiary of University of Texas System is an educational center that offers medical research and education programs. The center offers degree programs, which include master's degree in business administration, public health, medica …
  • Oil & Gas Development Co Ltd (OGDC):企業の財務・戦略的SWOT分析
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Tempur Sealy International, Inc.:企業の戦略・SWOT・財務情報
    Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tempur Sealy International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Great-West Life & Annuity Insurance Co:企業の戦略的SWOT分析
    Great-West Life & Annuity Insurance Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Aptinyx Inc (APTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptinyx Inc. (Aptinyx), formerly Enarex Inc, is a clinical-stage biopharmaceutical company that discovers and develops novel therapies for the treatment of neurological disorders. The company’s proprietary chemistry platform helps develop a pipeline of small-molecule modulators of N-methyl-D …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Power Corporation of Canada:企業の戦略・SWOT・財務情報
    Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report Summary Power Corporation of Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Imperial Oil Ltd (IMO):石油・ガス:M&Aディール及び事業提携情報
    Summary Imperial Oil Ltd (Imperial Oil), a subsidiary of Exxon Mobil Corporation, is an integrated energy company. It is present across the value chain in petroleum industry including the exploration, production and sale of crude oil and natural gas. The company explores for and produces crude oil, …
  • Albemarle Corporation:戦略・SWOT・企業財務分析
    Albemarle Corporation - Strategy, SWOT and Corporate Finance Report Summary Albemarle Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Havas SA:企業の戦略的SWOT分析
    Havas SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆